Anti-XCL2/ SCM-1b/ SCM1B functional antibody

Anti-XCL2/ SCM-1b/ SCM1B functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to XCL2/XCL2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1387-Ab-1/ GM-Tg-hg-SE1387-Ab-2Anti-Human XCL2 monoclonal antibodyHuman
GM-Tg-rg-SE1387-Ab-1/ GM-Tg-rg-SE1387-Ab-2Anti-Rat XCL2 monoclonal antibodyRat
GM-Tg-mg-SE1387-Ab-1/ GM-Tg-mg-SE1387-Ab-2Anti-Mouse XCL2 monoclonal antibodyMouse
GM-Tg-cynog-SE1387-Ab-1/ GM-Tg-cynog-SE1387-Ab-2Anti-Cynomolgus/ Rhesus macaque XCL2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1387-Ab-1/ GM-Tg-felg-SE1387-Ab-2Anti-Feline XCL2 monoclonal antibodyFeline
GM-Tg-cang-SE1387-Ab-1/ GM-Tg-cang-SE1387-Ab-2Anti-Canine XCL2 monoclonal antibodyCanine
GM-Tg-bovg-SE1387-Ab-1/ GM-Tg-bovg-SE1387-Ab-2Anti-Bovine XCL2 monoclonal antibodyBovine
GM-Tg-equg-SE1387-Ab-1/ GM-Tg-equg-SE1387-Ab-2Anti-Equine XCL2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg

Product Description

Catalog No.GM-Tg-hg-SE1387-Ab-1/ GM-Tg-hg-SE1387-Ab-2; GM-Tg-rg-SE1387-Ab-1/ GM-Tg-rg-SE1387-Ab-2;
GM-Tg-mg-SE1387-Ab-1/ GM-Tg-mg-SE1387-Ab-2; GM-Tg-cynog-SE1387-Ab-1/ GM-Tg-cynog-SE1387-Ab-2;
GM-Tg-felg-SE1387-Ab-1/ GM-Tg-felg-SE1387-Ab-2; GM-Tg-cang-SE1387-Ab-1/ GM-Tg-cang-SE1387-Ab-2;
GM-Tg-bovg-SE1387-Ab-1/ GM-Tg-bovg-SE1387-Ab-2; GM-Tg-equg-SE1387-Ab-1/ GM-Tg-equg-SE1387-Ab-2
Products NameAnti-XCL2 monoclonal antibody
Target NameXCL2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
Products descriptionPre-made anti-XCL2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


    Data / case study

    Click to get more Data / Case study about the product.

    Associated products

    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1387-Ag-1Recombinant multi-species XCL2/ SCM-1b/ SCM1B protein

    Target information

    Target IDGM-SE1387
    Target NameXCL2
    Gene ID6846
    Gene Symbol and SynonymsSCM-1b,SCM1B,SCYC2,XCL2
    Uniprot AccessionQ9UBD3
    Uniprot Entry NameXCL2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Gene EnsemblENSG00000143185
    Target ClassificationN/A

    The target: XCL2, gene name: XCL2, also named as SCM-1b, SCM1B, SCYC2. Predicted to enable CCR chemokine receptor binding activity and chemokine activity. Predicted to be involved in several processes, including cellular response to cytokine stimulus; leukocyte chemotaxis; and positive regulation of T cell chemotaxis. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022].

    About Gmab


    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.